AR-R15896AR, a low affinity, use-dependent, NMDA antagonist, is protective in a primate model of stroke

This publication has 18 references indexed in Scilit:

• Clomethiazole protects against hemineglect in a primate model of stroke
  Brain Research Bulletin, 2000
• The Low‐Affinity, Use‐Dependent NMDA Receptor Antagonist AR‐R 15896AR: An Update of Progress in Stroke
  Annals of the New York Academy of Sciences, 1999
• Efficacy of AR-R15896AR in the rat monofilament model of transient middle cerebral artery occlusion
  Journal Of Stroke & Cerebrovascular Diseases, 1999
• Functional Benefit from Clomethiazole Treatment after Focal Cerebral Ischemia in a Nonhuman Primate Species
  Experimental Neurology, 1999
• Lippincott‐Raven Publishers, Philadelphia © International League Against Epilepsy Remacemide Hydrochloride and ARL 15896AR Lack Abuse Potential: Additional Differences from Other Uncompetitive NMDA Antagonists
  Epilepsia, 1996
• Effects of anticonvulsants in a novel operant learning paradigm in rats: Comparison of remacemide hydrochloride and FPL 15896AR to other anticonvulsant agents
  Epilepsy Research, 1995
• Focal Cerebral Ischaemia in the Cat: Treatment with the Glutamate Antagonist MK-801 after Induction of Ischaemia
  Journal of Cerebral Blood Flow & Metabolism, 1988
• Glutamate Antagonist Therapy Reduces Neurologic Deficits Produced by Focal Central Nervous System Ischemia
  Archives of Neurology, 1988
• Protective Effect of the Glutamate Antagonist, MK-801 in Focal Cerebral Ischemia in the Cat
  Journal of Cerebral Blood Flow & Metabolism, 1988
• Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil
  Journal of Neuroscience, 1987